Lupus Nephritis Clinical Trials in Gainesville, Florida

4 studies are recruiting for lupus nephritis in Gainesville, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

    The primary objective of this trial is to evaluate the efficacy and safety of FT819, comprised of allogeneic T cells that express a CD19-targeted CAR, following bendamustine administration in participants with refractory moderate-to-severe lupus nephritis, as assessed by the proportion of participa…

    Stage
    Phase 2
    Ages
    12 to 70
    Site
    University of Florida Clinical Research Center, Gainesville, Florida
    Locations
    12 in total
    Run by
    Fate Therapeutics

    See if you can join NCT07570862 on ClinicalTrials.gov

  2. RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

    RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

    Stage
    Phase 1
    Ages
    18 to 65
    Site
    University of Florida Health, Gainesville, Florida
    Locations
    23 in total
    Run by
    Cabaletta Bio

    See if you can join NCT06121297 on ClinicalTrials.gov

  3. A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

    This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized dose escalation and dose expansion basket study to determine the safety and tolerability of NKX019 (allogeneic CAR NK cells targeting CD19) in participants with autoimmune diseases.

    Stage
    Phase 1
    Ages
    18 to 75
    Site
    Nkarta Investigational Site, Gainesville, Florida
    Locations
    19 in total
    Run by
    Nkarta, Inc.

    See if you can join NCT06557265 on ClinicalTrials.gov

  4. A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

    This is a phase 1 study designed to evaluate the safety, pharmacokinetics (PK), and anti-B-cell activity of FT819 following treatment with or without auxiliary medicinal product (AMP) in participants with moderate-to-severe active systemic lupus erythematosus (SLE) with or without nephritis, antine…

    Stage
    Phase 1
    Ages
    12 to 70
    Site
    University of Florida, Gainesville, Florida
    Locations
    21 in total
    Run by
    Fate Therapeutics

    See if you can join NCT06308978 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.